| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |